Multi-omics Mendelian randomization integrating metabolism, microbiome and immunity supports a putative gut-immune-pelvic pathway in deep infiltrating endometriosis - Report - MDSpire

Multi-omics Mendelian randomization integrating metabolism, microbiome and immunity supports a putative gut-immune-pelvic pathway in deep infiltrating endometriosis

  • By

  • Shanping Shi

  • Wei Song

  • Zhiping Wu

  • Yufeng Cheng

  • Hua Liu

  • Fuju Tian

  • Xiaocui Li

  • May 21, 2026

  • 0 min

Share

Clinical Report: Integrative Multi-Omics Mendelian Randomization in DIE

Overview

This study identifies potential causal links between metabolic, microbial, and immune factors and deep infiltrating endometriosis (DIE) using a multi-omics Mendelian randomization approach. A five-gene panel associated with DIE was identified, highlighting the complex interplay of these systems in the disease's pathology.

Background

Deep infiltrating endometriosis (DIE) is a severe form of endometriosis that significantly impacts women's health, causing debilitating pain and infertility. Understanding the underlying mechanisms, including metabolic and immune dysregulation, is crucial for developing effective treatments. This study explores the connections between gut microbiota, immune responses, and metabolic changes in the context of DIE.

Data Highlights

The study utilized two-sample Mendelian randomization to assess causal effects and identified 324 protein-coding genes associated with DIE.

Key Findings

  • Multiple circulating metabolites, gut microbiota traits, and immune cell phenotypes were linked to DIE susceptibility.
  • Risk-increasing factors included specific bile acid-related metabolites and certain bacterial taxa.
  • A five-gene panel (HDC, GADD45B, CDK5, AHNAK, RASGRP2) demonstrated excellent discrimination between DIE lesions and normal endometrium (AUC = 0.999).
  • Immunohistochemistry confirmed differential expression of key genes in DIE lesions.
  • Colocalization analysis revealed 42 differentially expressed genes enriched in inflammatory pathways.

Clinical Implications

The findings suggest that targeting metabolic and immune pathways may offer new therapeutic strategies for managing DIE. The identified five-gene panel could serve as a biomarker for diagnosis and monitoring of the disease.

Conclusion

This research supports a gut-immune-pelvic axis in DIE and highlights the potential for multi-omics approaches to uncover novel insights into the disease's pathophysiology.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. Diagnosis of Endometriosis | ACOG
  6. Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis - ScienceDirect
  7. Intraperitoneal translocation of gut microbiota induces NETosis and promotes endometriosis | Gut
  8. Diagnosis of Endometriosis | ACOG
  9. Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis - ScienceDirect
  10. Intraperitoneal translocation of gut microbiota induces NETosis and promotes endometriosis | Gut

Original Source(s)

Related Content